Literature DB >> 33179210

MiR-421 Aggravates Neurotoxicity and Promotes Cell Death in Parkinson's Disease Models by Directly Targeting MEF2D.

Yaru Dong1, Jing Xiong1, Liya Ji1, Xiuyun Xue2.   

Abstract

Parkinson's disease (PD) is a severe neurodegenerative disease characterized by selective loss of dopaminergic neurons, which reduces quality of life of patients and poses a heavy burden to the society. The pathological mechanism of PD remains unclear, and increasing efforts are aimed to solve this problem. MiRNAs are a kind of small noncoding RNA regulating target gene expression. Previous studies have shown that dysregulation of miRNAs is involved in the development of PD. In the present study, we determined that miR-421 and MEF2D are increased and decreased, respectively, in a cellular model of PD. The data on the mechanism of action indicate that miR-421 directly binds to MEF2D mRNA and negatively regulates MEF2D expression. An increase in miR-421 disrupted the Bcl2/Bax system. Functional assays indicated that enhanced miR-421 promotes cell death by negative modulation of MEF2D expression. Inhibition of miR-421 or restoration of MEF2D protected neurons from neurotoxicity in cellular and animal models of PD. Our study is the first to demonstrate that miR-421 is decreased in PD models and to determine a novel putative mechanism of PD pathogenesis.

Entities:  

Keywords:  6-OHDA; MEF2D; Parkinson’s disease; ROS; miR-421

Mesh:

Substances:

Year:  2020        PMID: 33179210     DOI: 10.1007/s11064-020-03166-0

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  26 in total

1.  Molecular biology. miRNAs in neurodegeneration.

Authors:  Sébastien S Hébert; Bart De Strooper
Journal:  Science       Date:  2007-08-31       Impact factor: 47.728

2.  MicroRNA-128 governs neuronal excitability and motor behavior in mice.

Authors:  Chan Lek Tan; Joshua L Plotkin; Morten T Venø; Melanie von Schimmelmann; Philip Feinberg; Silas Mann; Annie Handler; Jørgen Kjems; D James Surmeier; Dónal O'Carroll; Paul Greengard; Anne Schaefer
Journal:  Science       Date:  2013-12-06       Impact factor: 47.728

Review 3.  Effects of alpha-synuclein post-translational modifications on metal binding.

Authors:  Nazareno González; Trinidad Arcos-López; Annekatrin König; Liliana Quintanar; Mauricio Menacho Márquez; Tiago F Outeiro; Claudio O Fernández
Journal:  J Neurochem       Date:  2019-07-09       Impact factor: 5.372

4.  Serum and amygdala microRNA signatures of posttraumatic stress: fear correlation and biomarker potential.

Authors:  Nagaraja S Balakathiresan; Raghavendar Chandran; Manish Bhomia; Min Jia; He Li; Radha K Maheshwari
Journal:  J Psychiatr Res       Date:  2014-06-21       Impact factor: 4.791

5.  MicroRNA-421 suppresses the apoptosis and autophagy of hippocampal neurons in epilepsy mice model by inhibition of the TLR/MYD88 pathway.

Authors:  Xin Wen; Xin-Rui Han; Yong-Jian Wang; Shan Wang; Min Shen; Zi-Feng Zhang; Shao-Hua Fan; Qun Shan; Liang Wang; Meng-Qiu Li; Bin Hu; Chun-Hui Sun; Dong-Mei Wu; Jun Lu; Yuan-Lin Zheng
Journal:  J Cell Physiol       Date:  2018-03-25       Impact factor: 6.384

6.  Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson's disease.

Authors:  Ronglin Wang; Fangfang Lu; Gang Zhu; Dayun Feng; Tiejian Nie; Kai Tao; Shaosong Yang; Jie Lei; Lu Huang; Zixu Mao; Qian Yang
Journal:  Cell Death Dis       Date:  2018-06-07       Impact factor: 8.469

7.  ΜicroRNA‑421 promotes the progression of non‑small cell lung cancer by targeting HOPX and regulating the Wnt/β‑catenin signaling pathway.

Authors:  Huagang Liang; Chao Wang; Kun Gao; Jian Li; Rui Jia
Journal:  Mol Med Rep       Date:  2019-05-09       Impact factor: 2.952

8.  N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ATM pathway.

Authors:  Yu Yin; Lingfan Xu; Yan Chang; Tao Zeng; Xufeng Chen; Aifeng Wang; Jeff Groth; Wen-Chi Foo; Chaozhao Liang; Hailiang Hu; Jiaoti Huang
Journal:  Mol Cancer       Date:  2019-01-18       Impact factor: 27.401

9.  Potential miRNA-target interactions for the screening of gastric carcinoma development in gastric adenoma/dysplasia.

Authors:  Yu Jin Kim; Ki-Chul Hwang; Sang Woo Kim; Yong Chan Lee
Journal:  Int J Med Sci       Date:  2018-03-14       Impact factor: 3.738

10.  The Parkinson's disease gene product DJ-1 modulates miR-221 to promote neuronal survival against oxidative stress.

Authors:  Stephanie E Oh; Hye-Jin Park; Liqiang He; Catherine Skibiel; Eunsung Junn; M Maral Mouradian
Journal:  Redox Biol       Date:  2018-08-03       Impact factor: 11.799

View more
  6 in total

Review 1.  MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases.

Authors:  T P Nhung Nguyen; Mandeep Kumar; Ernesto Fedele; Giambattista Bonanno; Tiziana Bonifacino
Journal:  Int J Mol Sci       Date:  2022-04-25       Impact factor: 6.208

2.  Inhibition of miR-421 Preserves Mitochondrial Function and Protects against Parkinson's Disease Pathogenesis via Pink1/Parkin-Dependent Mitophagy.

Authors:  Xiaolin Dong; Xianghua He; Li Yang; Qingyun Li; Yanming Xu
Journal:  Dis Markers       Date:  2022-05-10       Impact factor: 3.464

3.  Long non-coding RNA ZFAS1 alleviates bupivacaine-induced neurotoxicity by regulating the miR-421/zinc finger protein564 (ZNF564) axis.

Authors:  Liuqing Yuan; Houren Xu; Rui Guo; Ting Lu; Xiaoling Li
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

4.  Mechanism of lncRNA SNHG16 in oxidative stress and inflammation in oxygen-glucose deprivation and reoxygenation-induced SK-N-SH cells.

Authors:  Xiangyuan Cao; Jingjing Ma; Shaohua Li
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

Review 5.  Crosstalk between regulatory non-coding RNAs and oxidative stress in Parkinson's disease.

Authors:  Hantao Zhang; Xiaoyan Liu; Yi Liu; Junlin Liu; Xun Gong; Gang Li; Min Tang
Journal:  Front Aging Neurosci       Date:  2022-08-09       Impact factor: 5.702

Review 6.  MicroRNAs in the epigenetic regulation of disease progression in Parkinson's disease.

Authors:  Sushmaa Chandralekha Selvakumar; K Auxzilia Preethi; Deusdedit Tusubira; Durairaj Sekar
Journal:  Front Cell Neurosci       Date:  2022-09-16       Impact factor: 6.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.